Psyence Biomedical
PBM on Nasdaq. Market value $7m.
Should I look at this?
We have not checked this company yet
This is not advice.
Who owns it
None of the long-term investors we follow own it. 9 funds in all.
Largest holders overall
- Parallel Advisors$574,750
- AdvisorShares Investments$373,883New
- Morgan Stanley$115,680New
- Jane Street Group$93,119New
- XTX Topco$46,188New
- Citadel Advisors$35,781New
- Stonehage Fleming Financial Services Holdings$272
- UBS Group AG$184New
- Caitlin John$107New
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
4 investors own more than 5%; 1 of them is pushing for change.
- Psyence Labs Ltd.49.8%+19.7 ptsSince 1 October 2026
What they said
Item 4 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: The Reporting Person acquired the Subject Shares pursuant to the exercise of an irrevocable put option granted to the Reporting Person under the Put Option Agreement, as previously…
Read the filing - AdvisorShares TrustPassive investor6.8%+6.0 ptsSince 30 September 2026
- Hudson Bay Capital Management LPPassive investorat least 5.0%−5.0 pts(filed with 1 related holder)Since 31 March 2025
- KAOS Capital Ltd.Activistat least 4.9%−11.9 pts(filed with 1 related holder)Since 8 January 2026
What they said
The Reporting Persons believe the securities of the Issuer represent an attractive investment opportunity but have significant concerns about the current management of the Company's assets. The Reporting Persons intend to communicate with the Issuer's management and Board about…
Read the filing - Weiner Jeffrey DavidPassive investorSold down below 5%Since 25 February 2026
- Harraden Circle Investments, LLCPassive investorSold down below 5%Since 31 March 2025
- Psyence Group Inc.Sold down below 5%Since 2 May 2025
What they said
The information set forth in Item 3 is hereby incorporated by reference in its entirety. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) and (c) through (j) of Item 4…
Read the filing
| Holder | Stake | Since | |
|---|---|---|---|
Psyence Labs Ltd. | 49.8%+19.7 pts | 1 October 2026 | What they saidItem 4 of the Original Schedule 13D is hereby amended and restated in its entirety as follows: The Reporting Person acquired the Subject Shares pursuant to the exercise of an irrevocable put option granted to the Reporting Person under the Put Option Agreement, as previously… Read the filing |
AdvisorShares Trust Passive investor | 6.8%+6.0 pts | 30 September 2026 | |
Hudson Bay Capital Management LP Passive investor | at least 5.0%−5.0 pts (filed with 1 related holder) | 31 March 2025 | |
KAOS Capital Ltd. Activist | at least 4.9%−11.9 pts (filed with 1 related holder) | 8 January 2026 | What they saidThe Reporting Persons believe the securities of the Issuer represent an attractive investment opportunity but have significant concerns about the current management of the Company's assets. The Reporting Persons intend to communicate with the Issuer's management and Board about… Read the filing |
Weiner Jeffrey David Passive investor | Sold down below 5% | 25 February 2026 | |
Harraden Circle Investments, LLC Passive investor | Sold down below 5% | 31 March 2025 | |
Psyence Group Inc. | Sold down below 5% | 2 May 2025 | What they saidThe information set forth in Item 3 is hereby incorporated by reference in its entirety. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) and (c) through (j) of Item 4… Read the filing |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
We have no insider filings for this company yet.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
Psyence Biomedical doesn’t file a US annual report (10-K), so we haven’t checked it.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.